Lockheed Martin's current market capitalization near $125 billion—more than double Anduril's $61 billion post-money valuation after its May 2026 Series H round—anchors trader consensus at 70% odds that it will hold the higher year-end figure. Lockheed's scale, supported by roughly $75 billion in annual revenue and entrenched U.S. defense contracts, provides a stable base less prone to sharp re-ratings, while Anduril's rapid expansion from $30.5 billion in mid-2025 reflects strong investor appetite yet starts from a smaller absolute level. Key catalysts include Lockheed's upcoming quarterly results, potential defense budget updates, and any Anduril IPO timeline that could compress or widen the valuation gap before December 31.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoAnduril
Anduril
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://polymarket.com/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Mercado abierto: May 19, 2026, 4:25 PM ET
Resolver
0x65070BE91...NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://polymarket.com/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Resolver
0x65070BE91...Lockheed Martin's current market capitalization near $125 billion—more than double Anduril's $61 billion post-money valuation after its May 2026 Series H round—anchors trader consensus at 70% odds that it will hold the higher year-end figure. Lockheed's scale, supported by roughly $75 billion in annual revenue and entrenched U.S. defense contracts, provides a stable base less prone to sharp re-ratings, while Anduril's rapid expansion from $30.5 billion in mid-2025 reflects strong investor appetite yet starts from a smaller absolute level. Key catalysts include Lockheed's upcoming quarterly results, potential defense budget updates, and any Anduril IPO timeline that could compress or widen the valuation gap before December 31.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes